Augma Biomaterials

Augma Biomaterials is a dynamic, innovative company focused on developing bone substitutes for bone augmentation in maxillofacial surgery. Their products are based on Biphasic Calcium Sulfate, a well-documented material with over 100 years of clinical success used as a bone graft substitute. Augma has developed bone graft cements such as 3D Bond™ and Bond Apatite® which provide advantages like improved handling, moldability, and accelerated setting even in the presence of blood and saliva. These materials are bioactive and promote true bone regeneration by stimulating the body`s own bone growth cells. The company`s mission is to produce natural mineral bone substitutes for dental applications, aiming for better handling and better clinical results that ultimately benefit patients` well-being. Augma provides education through in-person and online courses and supports clinicians to ensure faster and more predictable outcomes in dental surgery.